In addition, analyses of serum from myalgic encephalomyelitis and chronic fatigue syndrome patients (conditions that are considered closer to GWI patients) have revealed decreased levels of IL-16 and IL-7 (Landi et al., 2016). This evidence concerns the gene IL16 and myalgic encephalomeyelitis/chronic fatigue syndrome.